COVID-19 and tuberculosis coinfection: A case-control study from a tertiary care center in South India
Druti Hazra1, Nayana Siddalingaiah1, Nitin Gupta2
1Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Karnataka, India.
Insights
Coinfection with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) presents unique clinical features. Higher rates of upper lobe involvement and elevated biomarkers like C-reactive protein suggest TB in COVID-19 patients.
Area of Science:
- Infectious Diseases
- Pulmonology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are significant global health threats.
- Coinfection with COVID-19 and TB can complicate diagnosis and impact patient outcomes.
Purpose of the Study:
- To compare the clinical features and outcomes of patients coinfected with COVID-19 and TB against those with COVID-19 alone.
Main Methods:
- A retrospective case-control study was conducted from August 2020 to February 2022.
- 27 coinfected COVID-19-TB patients were matched with 27 COVID-19-only patients.
- Data analysis involved Chi-square tests and t-tests/Mann-Whitney U tests.
Main Results:
- Tuberculosis-COVID-19 coinfection showed significantly higher upper lobe involvement (44% vs. 7%) and pleural effusion (22% vs. 4%).
- Median levels of C-reactive protein and ferritin were significantly elevated in the coinfected group.
- A P-value < 0.05 indicated statistical significance.
Conclusions:
- Chest radiology findings and elevated biomarkers (C-reactive protein, ferritin) can aid in suspecting TB in COVID-19 patients, and vice versa.
- Early identification of coinfection is crucial for appropriate management and improved patient outcomes.
Context:
Coronavirus disease 2019 (COVID-19) and tuberculosis (TB), are presently the major infectious diseases imposing a consequential public health threat and their coinfection has a significant impact on the outcome.
Aims:
To evaluate the clinical features and outcomes of COVID-19-TB coinfected cases compared to solely COVID-19-infected cases.
Settings And Design:
A retrospective observational study was conducted between August 1, 2020, to February 28, 2022, at a tertiary care hospital.
Materials And Methods:
In this case-control study, an equal number of gender-age-matched COVID-19 and TB coinfected patients and COVID-19 cases without TB were included using simple random sampling.
Statistical Analysis Used:
The data was analyzed using SPSS v 26. Categorical variables were compared using the Chi-square test, and an independent t-test or Mann-Whitney U test was applied for the quantitative variables in the univariate analysis. A P-value of less than 0.05 was considered significant.
Results:
A total of 27 patients were included in each group. Upper lobe involvement (44%) and pleural effusion (22%) were significantly more common in TB-COVID-19 cases when compared to the control group (7% and 4%, respectively; P < 0.05). Moreover, median levels of C-reactive protein and ferritin were significantly higher in TB-COVID-19 coinfection.
Conclusions:
Chest radiology and a higher level of certain biomarkers like C-reactive protein and ferritin can help to suspect TB in COVID-19 patients and vice-versa.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...


